-+ 0.00%
-+ 0.00%
-+ 0.00%

Health Canada approves Aspen Pharmacare generic semaglutide injection

PUBT·07/20/2026 14:30:58
Listen to the news
Health Canada approves Aspen Pharmacare generic semaglutide injection
  • Health Canada granted Aspen approval for Aspen-Semaglutide, a generic semaglutide injectable for adults with type 2 diabetes.
  • Commercial rollout hinges on semaglutide API supply from Dr. Reddy's Laboratories, which has flagged temporary supply constraints.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Pharmacare Holdings Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S524353), on July 20, 2026, and is solely responsible for the information contained therein.